台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    85.4
  • 漲跌
    ▼0.1
  • 漲幅
    -0.12%
  • 成交量
    123
  • 產業
    上櫃 生技醫療類股
  • 117人加入追蹤

    立即追蹤

  • 本地時間:07:54

     
訊聯 (1784)籌碼相關-玉山-大里 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/037580859095May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

玉山-大里 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/0200.001284.4185.40-12242-4.95%
2025/04/0100.00386.6085.50-3248-1.21%
2025/03/280.386.4700.0090.000.32400.13%
2025/03/27690.351489.8489.00-8234-3.42%
2025/03/26188.60490.2589.50-3228-1.31%
2025/03/24186.00185.1085.1002230.00%
2025/03/21184.30386.0786.20-2221-0.90%
2025/03/19082.6000.0082.7002360.00%
2025/03/18180.80181.5081.5002470.00%
2025/03/07180.7000.0080.4013270.31%
2025/03/05182.6100.0082.8013490.29%
2025/03/03083.4000.0083.4003550.00%
2025/02/21187.80688.4285.50-5432-1.16%
2025/02/2000.00586.6086.00-5425-1.18%
2025/02/13084.4000.0084.1004340.00%
2025/02/12183.80183.0083.0004380.00%
2025/02/11783.6000.0082.6074421.58%
2025/02/07385.7300.0086.5034370.69%
2025/01/22082.8000.0083.1004370.00%
2025/01/13184.80179.6079.6004570.00%
2025/01/09183.0000.0082.5014660.21%
2024/12/2700.00281.7080.10-2495-0.40%
2024/12/20179.00379.2079.10-2544-0.37%
2024/12/19179.10279.4079.50-1547-0.18%
2024/12/18182.2000.0082.4015480.18%
2024/12/17283.3500.0083.4025820.34%
2024/12/13190.00091.8087.2015870.17%
2024/12/12495.30396.7092.6015800.17%
2024/12/11598.40297.2097.6035680.53%
2024/12/09092.7000.0092.3005610.00%
2024/12/055101.992100.0099.6035520.55%
2024/12/042102.258102.50100.50-6550-1.09%
2024/11/2500.00298.0097.40-2565-0.35%
2024/11/2000.002.396.4695.90-2.3565-0.40%
2024/11/1800.00288.2588.70-2627-0.32%
2024/11/1300.00089.2089.500643-0.01%
2024/11/12290.5000.0089.1026530.31%
2024/11/0800.00296.0094.10-2711-0.28%
2024/10/30291.4000.0091.4028430.24%
2024/10/2500.000.194.8094.80-0.1927-0.01%
2024/10/23199.9800.0099.8011,0120.10%
2024/10/2200.00196.7097.40-11,067-0.09%
2024/10/16396.93495.5594.50-11,554-0.06%
2024/10/11391.93492.3090.90-11,571-0.06%
2024/10/09196.10197.2096.1001,5850.00%
2024/10/08198.70198.2098.0001,5940.00%
2024/10/070.198.60299.5599.40-1.91,642-0.12%
2024/10/04197.6000.0098.8011,6850.06%
2024/10/014100.3800.00102.0041,6870.24%
2024/09/308102.691100.00100.0071,7060.41%
2024/09/2700.000.1100.0098.90-0.11,756-0.01%
2024/09/26199.6000.0098.5011,9640.05%
2024/09/242.197.71296.5596.600.12,2460.00%
2024/09/1910109.0000.00102.50102,2880.44%
2024/09/041110.5000.00109.0012,5940.04%
2024/09/0200.004116.50116.50-42,691-0.15%
2024/08/303116.671116.00116.5022,7630.07%
2024/08/291121.001118.00118.0002,8210.00%
2024/08/282.1121.962120.50119.000.12,8880.00%
2024/08/273120.171122.00122.0022,9580.07%
2024/08/261121.501121.00120.5002,9860.00%
2024/08/222116.751117.00114.5013,0030.03%
2024/08/211118.001117.00117.0002,9980.00%
2024/08/203115.172116.00116.0012,9730.03%
2024/08/1600.001113.00113.00-12,933-0.03%
2024/08/141112.002111.50112.00-12,956-0.03%
2024/08/1300.001112.00113.50-12,981-0.03%
2024/08/121115.5000.00112.0012,9620.03%
2024/08/072108.751107.50108.5012,9060.03%
2024/08/063102.00297.50103.0012,8900.03%
2024/08/051100.0000.0099.5012,8530.04%
2024/08/026115.3324111.71110.50-182,818-0.64%
2024/08/012119.008117.75117.00-62,802-0.21%
2024/07/3100.008117.50114.50-82,790-0.29%
2024/07/3000.0012117.42116.50-122,779-0.43%
2024/07/298124.065120.50113.5032,7480.11%
2024/07/2600.001126.00126.00-12,692-0.04%
2024/07/2319.3137.639.1132.47132.0010.22,6660.38%
2024/07/2213139.691142.50136.00122,6470.45%
2024/07/1942.1158.2817157.04145.5025.12,5720.98%
2024/07/187152.9415.1158.91161.50-8.12,302-0.35%
2024/07/172146.008144.75147.00-62,211-0.27%
2024/07/164142.008144.50141.50-42,198-0.18%
2024/07/151143.0014143.50143.50-132,196-0.59%
2024/07/1200.0013142.38139.00-132,177-0.60%
2024/07/116142.424142.00140.0022,1630.09%
2024/07/1012143.4615146.63147.50-32,144-0.14%
2024/07/0915143.772148.96143.50132,1300.61%
2024/07/081145.0143143.00146.00-422,083-2.02%
2024/07/0500.0010137.00133.00-102,039-0.49%
2024/07/0411130.0911134.18135.5002,0270.00%
2024/07/03117137.0759134.94133.00582,0082.89% 大買/
2024/07/0259135.5534137.90140.00251,9351.29%
2024/07/0125128.7218.2138.10139.506.91,7290.40%
2024/06/2824.1120.8518125.47127.006.11,6230.37%
2024/06/271115.5000.00115.5011,4360.07%
2024/06/26198.511101.00105.0001,4280.00%
2024/06/240.295.4600.0094.200.21,3710.01%
2024/06/212.197.08193.7093.701.11,3510.08%
2024/06/1900.000.297.5794.20-0.21,279-0.02%
2024/06/182.298.00293.3596.100.21,2420.02%
2024/06/17389.77692.3091.50-31,195-0.25%
2024/06/14286.10286.9587.7001,1530.00%
2024/06/13586.601186.1785.30-61,125-0.53%
2024/06/12282.55282.8083.4001,0690.00%
2024/06/11282.65187.0082.8011,0510.10%
2024/06/07682.62385.0783.0031,0170.29%
2024/06/06984.08181.2081.2089690.82%
2024/06/05283.35183.8087.0019070.11%
2024/06/04185.30383.3080.00-2836-0.24%
2024/06/03385.77483.1585.00-1773-0.13%
2024/05/31479.83678.1482.40-2690-0.29%
2024/05/30976.424.177.5977.304.96070.81%
2024/05/2900.0021.271.2374.00-21.2547-3.87%
2024/05/2800.00168.7068.80-1498-0.20%
2024/05/24166.8000.0067.2014930.20%
2024/05/23168.3000.0067.2014960.20%
2024/05/223069.902071.0069.60104872.05%
2024/05/2111.370.12270.1570.009.34791.94%
2024/05/202469.2622.169.8271.7024710.41%
2024/05/17368.13468.7869.90-1454-0.22%
2024/05/160.166.9000.0066.200.14220.01%
2024/05/0300.00166.2065.90-1385-0.26%
2024/05/02167.9000.0066.5013800.26%
2024/04/30165.00164.2064.2003620.00%
2024/04/29166.00166.0065.1003620.00%
2024/04/26168.70366.8066.40-2355-0.56%
2024/04/25266.0000.0069.4023090.65%
2024/04/2400.00063.2063.100291-0.01%
2024/04/23162.74164.6064.1002880.01%
2024/04/2200.00160.8060.80-1278-0.36%
2024/04/19960.5000.0058.8092813.19%
2024/04/1800.00161.4061.30-1276-0.36%
2024/04/17662.00161.9061.8052801.78%
2024/04/1600.00161.7061.40-1281-0.36%
2024/04/08066.9000.0066.5002700.00%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音